Topics
January/February 2016 | Special Focus: Inside The Treatment Pipeline
Reversing Retinal Ischemia
Using encapsulated cell technology, a novel device may some day be used to treat inadequate oxygenation associated with common diseases.
Logan Christensen, MD, and Jeffrey L. Olson, MD
July 17, 2026
Inflammasome Therapeutics Reports Positive Phase 2 Data for K8 in Geographic Atrophy
Curative Biotechnology Receives US Patent Allowance for Topical Metformin Therapy Targeting Retinal Degeneration
July 14, 2026
AMA Launches Interoperability Initiative to Advance Electronic Prior Authorization
Dompé Enrolls First Patient in Global Phase 3 Trial of Intranasal NGF Therapy for NAION
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Editorially independent content supported by advertising from Genentech
Free Print Subscription
Email Newsletter
Conference Calendar
